| 261 |
RUSODX |
RUXOLITINIB 15 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT OF MYELOFIBROSIS AND POLYCYTHEMIA VERA |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
10 L 1032/23 |
31-Oct-2023 |
30-Oct-2026 |
View |
| 262 |
RUSODX |
RUXOLITINIB 5 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT OF MYELOFIBROSIS AND POLYCYTHEMIA VERA |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 0963/23 |
28-APR-2023 |
27-APR-2026 |
View |
| 263 |
SALLYDX |
SELINEXOR 20 MG |
FILM COATED TABLET |
BOTTLE |
CONBINE WITH DEXAMETHASONE TO TREAT MYELOMA IN ADULT |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
05 L 0979/23 |
09-June-2023 |
08-June-2026 |
View |
| 264 |
SEMEDX |
SELUMETINIB 10 MG |
CAPSULE |
BOTTLE |
TO TREAT NEUROFIBROMATOSIS TYPE 1 (NF1, A NERVOUS SYSTEM DISORDER THAT CAUSES TUMORS TO GROW ON NERVES) IN CHILDREN 2 YEARS OF AGE AND OLDER WHO HAVE PLEXIFORM NEUROFIBROMAS (PN; SOFT TUMORS) THAT CANNOT BE COMPLETELY REMOVED BY SYRGERY. |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1085/24 |
29-MAR-2024 |
28-MAR-2027 |
View |
| 265 |
SEMEDX |
SELUMETINIB 25 MG |
CAPSULE |
BOTTLE |
TO TREAT NEUROFIBROMATOSIS TYPE 1 (NF1, A NERVOUS SYSTEM DISORDER THAT CAUSES TUMORS TO GROW ON NERVES) IN CHILDREN 2 YEARS OF AGE AND OLDER WHO HAVE PLEXIFORM NEUROFIBROMAS (PN; SOFT TUMORS) THAT CANNOT BE COMPLETELY REMOVED BY SYRGERY. |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1095/24 |
06-MAY-2024 |
05-MAY-2027 |
View |
| 266 |
SEPADX |
SELPERCATINIB 40 MG |
CAPSULE |
BOTTLE |
TREAT A CERTAIN TYPE OF NON SMALL CELL LUNG CANCER IN ADULT THAT HAS SPREAD TO NEARBY TISSUE OR OTHER PART OF THE BODY |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
10 L 1031/23 |
31-Oct-2023 |
30-Oct-2026 |
View |
| 267 |
SODADX |
SOFOSBUVIR 400 MG, VELPATASVIR 100 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREAMENT OF ADULT PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1,2,3,4,5,6 INFECTION |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1204/24 |
03-OCT-2024 |
02-OCT-2029 |
View |
| 268 |
SOTOLDX |
SOTORASIB 120 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT IN ADULTS WITH NSCLC |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
05 L 0978/23 |
09-June-2023 |
08-June-2026 |
View |
| 269 |
TAZEDX |
TAZEMETOSTAT 200 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULTS AND PEDIATRIC PATIENTS AGED 16 YEARS AND OLDER WITH METASTATIC OR LOCALLY ADVANCED EPITHELIOID SARCOMA NOT ELIGIBLE FOR COMPLETE RESECTION |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1139/24 |
12-JUL-2024 |
11-JUL-2027 |
View |
| 270 |
TEGLIDX |
TRELAGLIPTIN 100 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT OF DIABETE MELLITUS TYPE 2. |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
12 L 1055/23 |
03-JAN-2024 |
02-JAN-2027 |
View |
